A first case of congenital TTP on the African continent due to a new homozygous mutation in the catalytic domain of ADAMTS13

Annals of Hematology

Volumn 87, Issue 8, 2008, Pages 663-666

  Meyer, Sara C ^a   Jeddi, Ramzi ^b   Meddeb, Balkis ^b   Gouider, Emna ^b   Lämmle, Bernhard ^a   Kremer Hovinga, Johanna A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Hopital Aziza Othmana   (Tunisia)

Author keywords

ADAMTS13; Hereditary; Thrombotic thrombocytopenic purpura; TTP; Upshaw Schulman syndrome

Indexed keywords

CORTICOSTEROID; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AFRICA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; CATALYSIS; CEREBROVASCULAR ACCIDENT; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG PULSE THERAPY; GRAND MAL SEIZURE; HOMOZYGOSITY; HUMAN; IMMUNOTHERAPY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; RELAPSE; SYMPTOMATOLOGY; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; ADOLESCENT; CONSANGUINITY; HUMANS; MALE; MUTATION; PLASMA; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TUNISIA;

EID: 46949096955     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0496-6     Document Type: Article

References (11)

1. Lümmle B, Kremer Hovinga JA, Alberio L (2005) Thrombotic thrombocytopenic purpura. J Thromb Haemost 3:1663-1675
2. Levy GG, Nichols WC, Lian EC et al (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488-494
3. Kokame K, Matsumoto M, Soejima K et al (2002) Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Natl Acad Sci U S A 99:11902-11907
4. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T (2005) FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 129:93-100
5. Kremer Hovinga JA, Mottini M, Lämmle B (2006) Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay: Comparison with other assay methods. J Thromb Haemost 4:1146-1148
6. Furlan M, Robles R, Morselli B, Sandoz P, Lämmle B (1999) Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura. Thromb Haemost 81:8-13
7. Schneppenheim R, Budde U, Oyen F et al (2003) Von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP. Blood 101:1845-1850
8. Studt JD, Kremer Hovinga JA, Antoine G et al (2005) Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: In vitro inhibition of ADAMTS13 activity by hemoglobin. Blood 105:542-544
9. Furlan M, Lämmle B (2001) Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: The role of von Willebrand factor-cleaving protease. Best Pract Res Clin Haematol 14:437-454
10. Barbot J, Costa E, Guerra M et al (2001) Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease. Br J Haematol 113:649-651
11. Kinoshita S, Yoshioka A, Park YD et al (2001) Upshaw-Schulman syndrome revisited: A concept of congenital thrombotic thrombocytopenic purpura. Int J Hematol 74:101-108